NO20000079L - Ancrod specific monoclonal antibodies, antibody fragments, mixtures, derivatives and their use - Google Patents

Ancrod specific monoclonal antibodies, antibody fragments, mixtures, derivatives and their use

Info

Publication number: NO20000079L
Authority: NO; Norway
Prior art keywords: ancrod; mixtures; derivatives; monoclonal antibodies; antibody fragments
Prior art date: 1997-07-10

Application number

NO20000079A

Other languages

Norwegian (no)

Other versions

NO20000079D0 (en

Inventor

Thomas Subkowski

Wilfried Hornberger

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-10

Filing date

2000-01-07

Publication date

2000-03-07

2000-01-07 Application filed by Basf Ag filed Critical Basf Ag

2000-01-07 Publication of NO20000079D0 publication Critical patent/NO20000079D0/en

2000-03-07 Publication of NO20000079L publication Critical patent/NO20000079L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Public Health (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Pathology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20000079A 1997-07-10 2000-01-07 Ancrod specific monoclonal antibodies, antibody fragments, mixtures, derivatives and their use NO20000079L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19729544A DE19729544A1 (en)	1997-07-10	1997-07-10	Ancrod specific monoclonal antibodies, antibody fragments, their mixture or derivatives and their use
PCT/EP1998/003834 WO1999002564A2 (en)	1997-07-10	1998-06-23	Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same

Publications (2)

Publication Number	Publication Date
NO20000079D0 NO20000079D0 (en)	2000-01-07
NO20000079L true NO20000079L (en)	2000-03-07

Family

ID=7835268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000079A NO20000079L (en)	1997-07-10	2000-01-07	Ancrod specific monoclonal antibodies, antibody fragments, mixtures, derivatives and their use

Country Status (14)

Country	Link
US (1)	US6365155B1 (en)
EP (1)	EP1000087A2 (en)
JP (1)	JP2002511880A (en)
KR (1)	KR20010021649A (en)
CN (1)	CN1262690A (en)
AU (1)	AU748841B2 (en)
BR (1)	BR9810574A (en)
CA (1)	CA2295218A1 (en)
CZ (1)	CZ297216B6 (en)
DE (1)	DE19729544A1 (en)
IL (1)	IL133224A0 (en)
NO (1)	NO20000079L (en)
WO (1)	WO1999002564A2 (en)
ZA (1)	ZA986064B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI513466B (en) *	2010-01-20	2015-12-21	Boehringer Ingelheim Int	Anticoagulant antidotes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3841736A1 (en)	1988-12-10	1990-07-05	Basf Ag	ANCROD PROTEINS, THEIR PREPARATION AND USE
CA2015127A1 (en)	1989-04-26	1990-10-26	John G. Gray, Jr.	Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof
ES2090835T3 (en)	1992-02-17	1996-10-16	Akzo Nobel Nv	CALIBRATOR AND ITS USE IN AN IMMUNOLOGICAL TEST.
US5523292A (en)	1992-10-14	1996-06-04	Schwartz; Robert	Method of preventing restenosis following coronary angioplasty

1997
- 1997-07-10 DE DE19729544A patent/DE19729544A1/en not_active Withdrawn
1998
- 1998-06-23 EP EP98936383A patent/EP1000087A2/en not_active Withdrawn
- 1998-06-23 IL IL13322498A patent/IL133224A0/en unknown
- 1998-06-23 BR BR9810574-4A patent/BR9810574A/en not_active Application Discontinuation
- 1998-06-23 WO PCT/EP1998/003834 patent/WO1999002564A2/en active IP Right Grant
- 1998-06-23 CN CN98807040A patent/CN1262690A/en active Pending
- 1998-06-23 KR KR1020007000207A patent/KR20010021649A/en not_active Application Discontinuation
- 1998-06-23 US US09/446,983 patent/US6365155B1/en not_active Expired - Lifetime
- 1998-06-23 AU AU85406/98A patent/AU748841B2/en not_active Ceased
- 1998-06-23 CZ CZ20000057A patent/CZ297216B6/en not_active IP Right Cessation
- 1998-06-23 JP JP50805199A patent/JP2002511880A/en not_active Ceased
- 1998-06-23 CA CA002295218A patent/CA2295218A1/en not_active Abandoned
- 1998-07-09 ZA ZA9806064A patent/ZA986064B/en unknown
2000
- 2000-01-07 NO NO20000079A patent/NO20000079L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL133224A0 (en)	2001-03-19
AU748841B2 (en)	2002-06-13
KR20010021649A (en)	2001-03-15
EP1000087A2 (en)	2000-05-17
ZA986064B (en)	2000-01-10
CA2295218A1 (en)	1999-01-21
WO1999002564A3 (en)	1999-04-01
CN1262690A (en)	2000-08-09
DE19729544A1 (en)	1999-01-14
JP2002511880A (en)	2002-04-16
AU8540698A (en)	1999-02-08
CZ200057A3 (en)	2000-05-17
BR9810574A (en)	2000-09-19
US6365155B1 (en)	2002-04-02
WO1999002564A2 (en)	1999-01-21
CZ297216B6 (en)	2006-10-11
NO20000079D0 (en)	2000-01-07

Publication	Publication Date	Title
DK0941344T3 (en)	2004-09-27	Humanized anti-CD11a antibodies
FI956112A0 (en)	1995-12-19	Monoclonal anti-V integrin antibody
NO996551L (en)	2000-03-01	Enhanced anti-IgE antibodies and method for enhancing polypeptides
DE69920897D1 (en)	2004-11-11	MONOCLONAL ANTIBODIES WITH REDUCED IMMUNIZABILITY
CY2007012I2 (en)	2009-11-04	ANTI-VEGF ANTIBODIES
EP1071458A4 (en)	2005-02-16	Humanized antibody and uses thereof
DE69617896D1 (en)	2002-01-24	Human monoclonal antibody against VEGF
NO986050L (en)	1999-02-08	Purified surface antigen, sperm monoclonal antibody and its use
IL147517A0 (en)	2002-08-14	Monoclonal antibodies and immunoassay utilizing the same
LV11630A (en)	1996-12-20	T-dog antigen receptor V region full length proteins
DE69531958D1 (en)	2003-11-20	(1-3) -BETA-D-GLUUCON-BINDING PROTEIN, ANTIBODY DETECTING THIS PROTEIN AND USE OF THE PROTEIN AND ANTIBODY
HUP0103152A3 (en)	2004-03-01	Monoclonal antibodies directed against the g3bp protein, and uses
BR9509902A (en)	1997-10-21	Monoclonal antibody fragments showing immunosuppressive activity
EP0759943A4 (en)	1997-07-16	Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
BR9606978A (en)	1997-11-04	Monoclonal anti-idiotype (ab2) antibodies and their uses
DE3888604D1 (en)	1994-04-28	Monoclonal antibodies against antithrombin binding substance and its uses.
NO20011006D0 (en)	2001-02-27	High-affinity antibodies
NO20000079L (en)	2000-03-07	Ancrod specific monoclonal antibodies, antibody fragments, mixtures, derivatives and their use
AU3257399A (en)	1999-09-20	Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein
GB9718911D0 (en)	1997-11-12	Monoclonal antibodies
HUP0003029A3 (en)	2003-01-28	Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same
DE69020315D1 (en)	1995-07-27	MONOCLONAL ANTIBODY AGAINST C-REACTIVE PROTEIN.
DE69427850D1 (en)	2001-09-06	MONOCLONAL ANTIBODY AGAINST MUCOGLYCOPROTEIN
BR9709080A (en)	1999-08-03	Human anti-MP52 monoclonal antibody
IT1305309B1 (en)	2001-05-04	PROCEDURE FOR PURIFYING ANTI-THYROGLOBULIN ANTIBODIES AND USING THESE ANTIBODIES.

Legal Events

Date	Code	Title	Description
2004-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application